isati
indigotica
wide
use
chines
tradit
medicin
clinic
treatment
viru
infect
tumor
inflamm
yet
antivir
activ
remain
unclear
studi
probe
antivir
activ
indigotica
extract
marker
compound
japanes
enceph
viru
jev
indigotica
methanol
extract
indigo
indirubin
prove
less
cytotox
compon
show
inhibitori
effect
concentrationdepend
jev
replic
vitro
timeofaddit
experi
prove
extract
indigo
indirubin
potent
antivir
effect
pretreat
infect
simultan
treatment
infect
posttreat
entri
antivir
action
agent
show
correl
block
viru
attach
exhibit
potent
virucid
activ
particular
indirubin
strong
protect
abil
mous
model
lethal
jev
challeng
studi
could
yield
antijev
agent
isati
indigotica
herb
distribut
wide
china
tradit
use
clinic
treatment
viral
diseas
like
influenza
hepat
enceph
accumul
experiment
evid
indic
relat
compon
associ
antivir
activ
influenza
sarscoronaviru
footandmouth
diseas
rabi
human
immunodefici
viru
type
among
other
among
natur
compound
identifi
indigoticafor
exampl
indican
isatin
indirubin
indigotin
indirubin
exhibit
multipl
immunomodulatori
antivir
effect
japanes
enceph
viru
jev
belong
genu
flaviviru
flavivirida
famili
arthropodborn
microorgan
vaccin
current
avail
effect
yet
virus
zoonot
characterist
occasion
infect
caus
jev
rank
lead
caus
high
morbid
mortal
rate
southeast
asia
western
pacif
region
je
patient
develop
perman
neuropsychiatr
sequela
je
case
result
death
extens
studi
develop
new
therapeut
strategi
may
need
studi
rate
inhibitori
effect
ethyl
acet
methanol
water
extract
indigotica
along
relat
natur
compound
jev
replic
prove
pretreat
indigotica
extract
indigo
indirubin
greatli
inhibit
jev
replic
vitro
agent
block
jev
attach
correl
potent
virucid
activ
jev
strain
use
previous
describ
vero
cell
jev
amplif
maintain
dulbecco
modifi
eagl
medium
dmem
well
cell
use
determin
jev
plaqu
grown
minimum
essenti
medium
mem
supplement
fetal
bovin
serum
fb
human
promonocyt
hlcz
cell
cultur
medium
serv
determin
jev
yield
vitro
crude
extract
powder
indigotica
obtain
sun
ten
pharmaceut
co
ltd
taiwanes
manufactur
evidencebas
complementari
altern
medicin
concentr
herbal
extract
extract
test
g
powder
dissolv
ml
ethyl
acet
methanol
gentli
shaken
overnight
room
temperatur
extract
solut
collect
follow
centrifug
rpm
min
filter
use
whatman
number
filter
paper
lyophil
use
freez
dryer
iwaki
lyophil
extract
powder
kept
steril
bottl
c
stock
extract
solut
mgml
dissolv
phosphatebuff
salin
pb
steril
use
syring
filter
store
c
use
marker
compound
indigotica
like
adenosin
betulin
indigo
indirubin
tryptanthrin
lupeol
purchas
sigma
chemic
co
st
loui
mo
stock
solut
marker
compound
mgml
dissolv
dimethyl
sulfoxid
dmso
dilut
pb
dmso
test
solvent
control
calcul
cytotox
cell
human
promonocyt
cell
cell
cultur
overnight
plate
medium
contain
dmso
indigotica
extract
marker
compound
ad
incub
anoth
hour
live
cell
total
hlcz
cell
count
treatment
measur
stain
trypan
blue
viabil
estim
ratio
livingtot
cell
count
quadrupl
well
analyz
concentr
cytotox
concentr
show
toxic
effect
cc
deriv
comput
program
provid
john
spoug
nation
center
biotechnolog
inform
nation
institut
health
test
inhibitori
effect
indigotica
jev
yield
human
promonocyt
cell
hlcz
cell
infect
jev
multipl
infect
treat
dmso
indigotica
extract
marker
compound
time
h
inocul
cultur
supernat
un
treat
jevinfect
cell
collect
measur
viru
yield
plaqu
assay
serial
dilut
cultur
medium
ad
well
cell
monolay
c
h
overlaid
mem
medium
contain
methylcellulos
viral
plaqu
stain
naphthol
blueblack
dye
threeday
incub
gaug
inhibitori
effect
indigotica
time
addit
jev
replic
vitro
pretreat
prior
infect
simultan
treatment
time
infect
posttreat
entri
experi
perform
pretreat
experi
cell
monolay
pretreat
withwithout
variou
dmso
concentr
indigotica
extract
marker
compound
infect
cell
monolay
overlaid
mem
medium
contain
methylcellulos
h
infect
viral
plaqu
stain
naphthol
blueblack
dye
threeday
incub
simultan
treatment
medium
withwithout
variou
dmso
concentr
indigotica
extract
marker
compound
mix
along
jev
pfu
forthwith
ad
well
cell
monolay
c
h
overlaid
mem
medium
contain
methylcellulos
viral
plaqu
assay
posttreat
assay
cell
monolay
infect
jev
pfu
h
follow
h
incub
drug
solut
overlaid
mem
medium
contain
methylcellulos
describ
plaqu
assay
data
repres
mean
sd
three
independ
experi
inhibitori
concentr
show
jev
plaqu
reduct
ic
determin
comput
program
john
spoug
nation
center
biotechnolog
inform
nation
institut
health
assay
jev
pfu
mix
medium
contain
variou
concentr
dmso
indigotica
extract
marker
compound
immedi
incub
cell
monolay
c
allow
attach
h
incub
extractviru
compoundviru
mixtur
remov
cell
monolay
wash
cold
pb
overlaid
mem
medium
contain
methylcellulos
incub
c
co
incub
plaqu
stain
describ
plaqu
assay
virucid
assay
base
prior
report
jev
pfu
mix
medium
contain
dmso
indigotica
extract
marker
compound
incub
min
c
dilut
extractviru
compoundviru
mixtur
ad
onto
cell
monolay
plate
h
incub
mixtur
remov
wash
pb
monolay
overlaid
mem
medium
contain
methylcellulos
residu
infect
inhibitori
concentr
show
jev
plaqu
reduct
ic
determin
describ
plaqu
assay
assay
group
n
balbc
mice
intracerebr
infect
pfu
virul
jev
strain
underw
three
intracerebr
treatment
indigotica
extract
marker
compound
mgkg
bodi
weight
use
syring
h
infect
two
addit
group
infect
jev
receiv
pb
dmso
treatment
solvent
control
surviv
rate
monitor
everi
day
one
week
statist
analysi
anova
use
spss
program
version
spss
inc
il
usa
student
ttest
analyz
data
p
valu
less
consid
statist
signific
compound
test
cytotox
hlcz
cell
treat
indigotica
extract
relat
marker
compound
concentr
sinc
dilut
solut
indigo
indirubin
contain
dmso
cell
also
treat
serial
dilut
dmso
solvent
control
tabl
indigotica
relat
marker
compound
like
tryptanthrin
adenosin
betulin
lupeol
show
high
toxic
cell
line
cc
compar
ethyl
acet
methanol
extract
indigo
indirubin
manifest
low
toxic
cell
avail
vitro
vivo
activ
jev
show
dosedepend
inhibit
jev
replic
hlcz
promonocyt
cell
timedepend
inhibitori
effect
jev
product
vitro
particularli
indigo
indirubin
show
viru
yield
reduc
approxim
h
incub
tabl
indigo
indirubin
talli
therapeut
index
cc
ic
meanwhil
dilut
dmso
signific
effect
plaqu
reduct
data
shown
preand
posttreat
plaqu
reduct
assay
test
antivir
effect
indigotica
jev
replic
pretreat
assay
indigo
indirubin
pretreat
jev
adsorpt
show
antivir
activ
similar
simultan
treatment
assay
figur
tabl
howev
posttreat
indigotica
extract
indigo
indirubin
ineffect
antivir
activ
viru
entri
result
demonstr
pretreat
indigotica
extract
indigo
indirubin
affect
jev
replic
vitro
rate
inhibitori
effect
indigotica
viru
attach
jev
mixtur
pfu
indigotica
extract
indigo
indirubin
dmso
solvent
control
immedi
incub
c
cell
monolay
allow
attach
alon
viru
attach
c
h
mixtur
remov
cell
monolay
wash
pb
residu
infect
deriv
plaqu
assay
yield
ic
valu
methanol
extract
indigo
indirubin
preand
simultan
treatment
figur
tabl
howev
dmso
signific
effect
viru
attach
data
shown
result
demonstr
potent
inhibitori
effect
methanol
extract
indigo
indirubin
jev
attach
ascertain
whether
indigotica
virucid
action
directli
interf
viru
particl
jev
preincub
indigo
indirubin
c
h
residu
infect
test
plaqu
assay
figur
tabl
indigo
indirubin
exhibit
concentrationdepend
virucid
activ
well
signific
inhibitori
effect
residu
infect
compar
control
virucid
ic
valu
jev
ethyl
acet
extract
methanol
extract
indigo
indirubin
moreov
virucid
ic
valu
pre
simultan
posttreat
well
viru
attach
assay
tabl
reveal
indigotica
directli
inactiv
jev
particl
exhibit
potent
virucid
action
investig
vivo
protect
potenti
indigotica
group
mice
intracerebr
challeng
lethal
dose
virul
jev
strain
treat
extract
indigo
indirubin
pb
dmso
h
infect
surviv
rate
indirubintr
group
day
infect
starkli
higher
other
exampl
indigo
ethyl
acet
extracttr
figur
none
methanol
extract
pb
dmsotreat
group
surviv
indic
indirubin
superior
indigo
ethyl
acet
extract
better
methanol
extract
mous
protect
lethal
ic
challeng
jev
studi
demonstr
indigotica
extract
low
cytotox
concentrationdepend
inhibitori
effect
jev
replic
vitro
exampl
reduc
viru
yield
block
viru
attach
virucid
activ
figur
tabl
indigotica
extract
display
multipl
antivir
immunomodulatori
activ
footandmouth
diseas
rabi
influenza
sarscoronaviru
result
indic
antivir
potenti
indigotica
jev
among
relat
compound
indirubin
manifest
potent
antijev
activ
plaqu
reduct
ic
via
simultan
treatment
viru
attach
inhibit
ic
virucid
inactiv
ic
figur
tabl
indirubin
also
concentrationdepend
reduc
viru
yield
cell
cultur
figur
b
indigo
effect
inhibit
jev
replic
vitro
reduc
viru
yield
attach
figur
b
b
show
greater
virucid
activ
ic
indigotica
extract
indirubin
indigo
potent
virucid
activ
directli
inactiv
viru
particl
link
better
inhibit
jev
replic
pretreat
signific
reduct
viru
attach
yield
vitro
similar
antivir
effect
indirubin
pseudorabi
viru
also
report
inconsist
antijev
abil
among
reduc
viru
yield
viru
attach
virucid
activ
could
due
possibl
cell
rapidli
uptak
indirubin
indigo
metabol
inact
product
support
prior
report
indirubin
potent
vivo
protect
intracerebr
jev
challeng
lethal
dose
indigo
ethyl
acet
extract
methanol
extract
figur
indirubin
likewis
regul
immunomodulatori
activ
rant
express
influenzainfect
bronchial
epitheli
cell
show
broadspectrum
antivir
activ
effect
virucid
action
jev
sum
indigotica
contain
potenti
antivir
compon
jev
forth
virucid
action
among
major
indigotica
compon
indirubin
manifest
potenti
antivir
activ
jev
infect
could
yield
new
antijev
agent
